Biofrontera Inc.
BFRIW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $4.48K in total; no superinvestor holds it.
Other share classesBFRI
Q2 2022 vs. Q1 2022
How the institutions holding Biofrontera Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 2 | 6 | +4 |
| Shares | 271.0K | 332.2K | +61.2K (+22.6%) |
| Value | $396.0K | $236.0K | −$160.0K (−40.4%) |
New holders (4)
Institutions that held Biofrontera Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 26,152 | $18.0K | 0.00% |
| Warberg Asset Management LLC | 13,451 | $10.0K | 0.00% |
| Clear Street LLC | 12,790 | $9.00K | 0.00% |
| UBS Group AG | 3,853 | $3.00K | 0.00% |
Sold out (0)
Institutions that held Biofrontera Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
None.